RMD News: BIO Stock Might Rise Following the Offer to Acquire Stilla - 18th Feb 2025, 11:30pm

[annb0t]

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement Bio-Rad’s digital PCR portfolio. The acquisition should further expand Bio-Rad’s business into applied research and clinical diagnostics, where customers expect a higher degree of automation and throughput capabilities.

The acquisition is subject to consultation with relevant employee...

>>> Read more: BIO Stock Might Rise Following the Offer to Acquire Stilla